Full Text View
Tabular View
Study Results
Related Studies
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
This study has been completed.
Study NCT00932477   Information provided by Allergan

First Received on July 1, 2009.   Last Updated on November 9, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dry Eye Syndrome
Additional conditions recognized in this trial
Dry Eye Syndromes
Keratoconjunctivitis Sicca
More general conditions related to this trial
Conjunctival Diseases
Conjunctivitis
Corneal Diseases
Eye Diseases
Keratitis
Keratoconjunctivitis
Lacrimal Apparatus Diseases
Additional drug interventions recognized in this trial
Carboxymethylcellulose Sodium
Glycerol
More general drug interventions related to this trial
Cryoprotective Agents
Gastrointestinal Agents
Laxatives
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Allergan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services